首页> 美国卫生研究院文献>International Journal of Neuropsychopharmacology >PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy

【2h】

PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy

机译：PS118。氯胺酮和孕烯醇酮-甲基醚（3ß-甲氧基-孕烯醇酮）的单次给药在抗抑郁药的临床前模型中具有抗抑郁功效：药理功效的血浆生物标志物的鉴定

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 International Journal of Neuropsychopharmacology
作者
Prenderville Jack; Bianchi Massimiliano; Grazia Di Capua; McDonnell Conor; Rouine Jennifer;
展开▼
作者单位

展开▼
年(卷),期 2016(19),Suppl 1
年度 2016
页码 40
总页数 1
原文格式 PDF
正文语种
中图分类神经科学;药学;神经病学;精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3?-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy [J] . The international journal of neuropsychopharmacology . 2016,第Suppla1期

机译：PS118。氯胺酮和孕烯醇酮-甲基醚（3′-甲氧基-孕烯醇酮）的单次给药在抗抑郁药的临床前模型中具有抗抑郁功效：药理功效的血浆生物标志物的鉴定
2. PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3?-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy [J] . The international journal of neuropsychopharmacology . 2016,第Suppla1期

机译：PS118。氯胺酮和孕烯醇酮-甲基醚（3′-甲氧基-孕烯醇酮）的单次给药在抗抑郁药的临床前模型中具有抗抑郁功效：药理功效的血浆生物标志物的鉴定
3. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: Preclinical and clinical efficacy [J] . RogózZ. Pharmacological reports: PR . 2013,第6期

机译：非典型抗精神病药和抗抑郁药联合治疗难治性抑郁症的临床前和临床疗效
4. CAT-02-106, a Site-Specifically Conjugated Anti-CD22 Antibody Bearing an MDRl-Resistant Maytansine Payload, Yields Excellent Efficacy and Safety in Preclinical Models [C] . Robyn Μ. Barfield, Penelope Μ. Drake, Adam Carlson, Protein Engineering Summit. . 2018

机译：CAT-02-106，一种耐受MDRL抗性Maytansine有效载荷的位点特异性缀合的抗CD22抗体，在临床前模型产生优异的功效和安全性
5. Efficacy of cognitive -behavioral, pharmacological, and combined treatments of depression: A meta-analysis. [D] . Chan, Eric King-Hay. 2006

机译：认知行为，药理学和抑郁综合治疗的功效：一项荟萃分析。
6. D-serine plasma concentration is a potential biomarker of (RS)-ketamine antidepressant response in subjects with treatment-resistant depression [O] . Ruin Moaddel, David A. Luckenbaugh, Ying Xie, -1

机译：D-丝氨酸血浆浓度是治疗难治性抑郁症患者（RS）-氯胺酮抗抑郁反应的潜在生物标志物
7. D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression [O] . Ruin Moaddel, David A. Luckenbaugh, Ying Xie, 2014

机译：D-丝氨酸等离子体浓度是（R，S）-Ketamine抗抑郁症反应的潜在生物标志物，其受试者耐治疗抑郁症

PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy

著录项

引文网络

相似文献

相关主题

期刊订阅